Adaptive Immunity: Generating T-Cell and B-Cell Receptor Diversity & B-Lymphocyte Function

Introduction

This lecture delves into the remarkable ability of the adaptive immune system to recognize a virtually limitless array of antigens. This capacity is primarily due to the vast diversity of T-cell receptors (TCRs) and B-cell receptors (BCRs), the latter of which are also secreted as antibodies. We will explore:

The fundamental challenge of generating immunological diversity.
The structural similarities and differences between TCRs and BCRs/antibodies.
The genetic mechanisms responsible for generating receptor diversity, primarily V(D)J recombination and junctional diversity.
The development and maturation of B-lymphocytes in the bone marrow, including processes of central tolerance.
The activation of B-cells in secondary lymphoid organs, focusing on T-cell dependent activation.
Processes that further refine B-cell responses: somatic hypermutation and class switch recombination.
The differentiation of B-cells into antibody-secreting plasma cells and long-lived memory B-cells.
The different classes (isotypes) of immunoglobulins (IgM, IgG, IgA, IgD, IgE) and their specific effector functions.

I. The Challenge and Mechanisms of Immunological Diversity

The adaptive immune system must be prepared to recognize an enormous number of potential pathogens it has never encountered. Early estimates predicted the need for 107 or more different antibodies in mice. If each antibody was encoded by a separate gene, this would require an impossibly large portion of the genome (e.g., sim2times1010 nucleotides, far exceeding the entire mouse genome of sim2.8times109 nucleotides). This paradox was solved by the discovery that antigen receptor genes are assembled from smaller gene segments through a process of somatic DNA recombination.

A. Structure of B-Cell Receptors (BCRs) / Antibodies and T-Cell Receptors (TCRs):

BCR/Antibody Structure:
- A typical antibody molecule (e.g., IgG) is Y-shaped and composed of four polypeptide chains: two identical heavy (H) chains and two identical light (L) chains (either kappa, κ, or lambda, λ), held together by disulfide bonds.
- Each chain has variable (V) regions at the N-terminus and constant (C) regions at the C-terminus.
- Antigen-Binding Site: Formed by the V regions of one H chain and one L chain (VH and VL). Each antibody monomer has two identical antigen-binding sites.
 - Complementarity Determining Regions (CDRs) / Hypervariable Regions (HVs): Within the V regions are short stretches of hypervariable amino acid sequences (CDR1, CDR2, CDR3). These CDRs form the actual antigen-binding surface and are the most variable parts of the molecule, determining its specificity. CDR3 typically shows the greatest variability. Less variable sequences within the V regions are called framework regions.
- Fab (Fragment antigen-binding) region: Consists of one L chain and the VH and CH1 domains of one H chain; contains one antigen-binding site.
- Fc (Fragment crystallizable) region: Formed by the C-terminal constant domains of the two H chains (CH2 and CH3 for IgG). The Fc region mediates effector functions by interacting with Fc receptors on immune cells and with complement proteins.
- Hinge Region: A flexible region in the H chain (between CH1 and CH2 in IgG and IgA) allowing movement of the Fab arms.
- BCR: Membrane-bound form of antibody on the B-cell surface, includes a short transmembrane segment.
- Antibody: Secreted form of the BCR, lacking the transmembrane segment (produced by alternative RNA processing).
TCR Structure:
- Most TCRs are heterodimers consisting of an α chain and a β chain (or less commonly, a γ and a δ chain), linked by a disulfide bond.
- Each chain has an N-terminal V region and a C-terminal C region, and a transmembrane segment.
- Antigen-Binding Site: Formed by the Vα and Vβ regions. Like antibodies, TCR V regions have CDRs (CDR1, CDR2, CDR3) that determine specificity for MHC-peptide complexes.
- TCRs are always membrane-bound and are not secreted.

B. Key Differences in Antigen Recognition by BCRs and TCRs:

Feature	B-Cell Receptor (BCR) / Antibody	T-Cell Receptor (TCR)
Antigen Recognized	Can recognize free, native antigen (proteins, polysaccharides, lipids, nucleic acids)	Only recognizes processed peptide fragments presented by MHC molecules on APCs or target cells
Form	Membrane-bound (BCR) or secreted (antibody)	Membrane-bound only
Interaction Strength	Can have very strong interaction with antigen	Generally weaker interaction with MHC-peptide
MHC Requirement	Not needed for antigen recognition	MHC presentation is essential
Antigen Epitopes	Can recognize continuous (linear) or discontinuous (conformational) epitopes	Recognizes primarily linear peptide epitopes bound in MHC groove

C. Generation of Receptor Diversity: Somatic Recombination (Gene Rearrangement):

The vast diversity of BCRs and TCRs is primarily generated by a process of somatic DNA recombination called V(D)J recombination. This occurs during lymphocyte development in the primary lymphoid organs (bone marrow for B-cells, thymus for T-cells).

Gene Segments: Immunoglobulin (Ig) and TCR genes are not encoded as continuous units in the germline DNA. Instead, the V regions are assembled from discrete gene segments:
- V (Variable) segments: Encode most of the V region.
- D (Diversity) segments: Found only in Ig heavy chains and TCR β (and δ) chains; contribute to CDR3.
- J (Joining) segments: Encode the remainder of the V region, including part of CDR3.
- C (Constant) segments: Encode the C region of the chains (e.g., Cµ, Cδ, Cγ, Cε, Cα for Ig heavy chains; Cκ, Cλ for Ig light chains; Cα, Cβ for TCR chains).
Recombination Process:
- Ig Heavy Chain (and TCR β/δ chains):
  1. D-J joining: One D segment is randomly joined to one J segment.
  2. V-DJ joining: One V segment is randomly joined to the fused DJ segment. This forms a complete VDJ exon encoding the V region.
- Ig Light Chain (κ or λ) (and TCR α/γ chains):
  1. V-J joining: One V segment is randomly joined to one J segment, forming a complete VJ exon.
Enzymology: V(D)J recombination is mediated by a set of enzymes collectively called the V(D)J recombinase. Key components include:
- RAG-1 and RAG-2 (Recombination Activating Genes): Lymphocyte-specific proteins that recognize Recombination Signal Sequences (RSSs) flanking the V, D, and J segments and introduce double-strand DNA breaks.
- DNA repair enzymes: General DNA repair machinery (e.g., DNA ligase IV, Artemis, Ku70/80, DNA-PKcs) that resolve the breaks and join the segments.
Recombination Signal Sequences (RSSs) and the 12/23 Rule:
- Each V, D, and J segment is flanked by an RSS, which consists of a conserved heptamer (7 bp) sequence and a conserved nonamer (9 bp) sequence, separated by either a 12 bp spacer or a 23 bp spacer.
- 12/23 Rule: Recombination can only occur efficiently between an RSS with a 12 bp spacer and an RSS with a 23 bp spacer. This ensures that, for example, a V segment joins to a D segment (or J segment if no D is present), but not directly to another V segment.
Post-Recombination Events for Ig Heavy Chain:
1. The rearranged VDJ segment is initially transcribed along with the nearest C region genes (Cµ and Cδ for IgM and IgD) to form a primary RNA transcript.
2. RNA processing (splicing) joins the VDJ exon to either the Cµ or Cδ exons, generating mRNA for either the µ heavy chain (for IgM) or the δ heavy chain (for IgD). Naïve B-cells often co-express IgM and IgD with the same VDJ region.
3. Translation produces the heavy chain protein, which is then transported to the ER for assembly with a light chain to form the BCR.

D. Additional Mechanisms Contributing to Diversity:

Combinatorial Diversity:
- Multiple Germline Segments: The genome contains multiple different V, D, and J gene segments for each chain type (see table below). The random selection of one of each type contributes significantly to diversity. | Element | Ig H Chain | Ig L Chain (κ or λ) | TCR α Chain | TCR β Chain | | :---------------- | :--------- | :------------------ | :---------- | :---------- | | Variable (V) | ~40 | ~59 (κ+λ) | ~70 | ~52 | | Diversity (D) | ~27 | 0 | 0 | 2 | | Joining (J) | ~6 | ~9 (κ+λ) | ~61 | ~13 |
- Pairing of Chains: The pairing of different rearranged heavy chains with different rearranged light chains (for BCRs/antibodies) or different α chains with different β chains (for TCRs) further multiplies the potential diversity (e.g., sim2times106 possible V gene pairs for Ig, sim6times106 for αβ TCR).
Junctional Diversity:
- Imprecise joining of V, D, and J segments during recombination introduces additional variability at the junctions, which correspond to the highly variable CDR3 regions.
- Mechanisms include:
  - P-nucleotide addition: RAG-mediated cleavage can create hairpin loops at the coding ends. Asymmetric opening of these hairpins by Artemis can lead to the addition of short palindromic sequences.
  - N-nucleotide addition: Terminal deoxynucleotidyl Transferase (TdT), a lymphocyte-specific enzyme, randomly adds non-templated nucleotides to the exposed DNA ends before they are ligated. This is a major source of CDR3 diversity.
  - Exonuclease trimming: Nucleotides can be removed from the ends of segments before joining.
- Junctional diversity can increase receptor diversity by an order of 107 to 1011 and is fundamental for full antigen coverage.
Somatic Hypermutation (BCRs/Antibodies Only):
- After B-cell activation in germinal centers, the V regions of Ig genes undergo a high rate of point mutations.
- This process, mediated by the enzyme Activation-Induced Cytidine Deaminase (AID), allows for the selection of B-cells producing antibodies with progressively higher affinity for the antigen (affinity maturation).
- Somatic hypermutation does not occur in TCR genes.
Total Estimated Diversity:
- Ig (excluding somatic hypermutation): sim1013 possible specificities.
- αβ TCR: sim1018 possible specificities.

II. B-Lymphocyte Development

B-cells develop from hematopoietic stem cells (HSCs) in the bone marrow. This process involves sequential Ig gene rearrangements and selection checkpoints to ensure functionality and self-tolerance.

Stages of B-Cell Development in Bone Marrow: Interaction with bone marrow stromal cells (which provide signals like the chemokine CXCL12 and the cytokine IL-7) is crucial.

Hematopoietic Stem Cell (HSC) → Common Lymphoid Progenitor (CLP).
Pre-Pro-B cell: Minimal Ig gene rearrangement. Starts to express B-lineage specific transcription factors.
Pro-B cell (Early and Late):
- D-JH joining on the heavy chain locus occurs first.
- Then VH-DJH joining occurs. Successful rearrangement leads to the production of a µ heavy chain.
Pre-B cell (Large and Small):
- The µ heavy chain pairs with surrogate light chains (VpreB and λ5) and Igα/Igβ signaling molecules to form the pre-B cell receptor (pre-BCR).
- Signaling from the pre-BCR promotes:
  - Survival and proliferation (several rounds of division in large pre-B cells).
  - Allelic exclusion (prevents rearrangement of the other heavy chain allele).
  - Initiation of light chain gene rearrangement (κ locus first, then λ if κ is unsuccessful).
Immature B-cell:
- Successful VL-JL rearrangement leads to the production of a light chain (κ or λ), which pairs with the µ heavy chain to form a complete, membrane-bound IgM B-cell receptor (BCR).
- At this stage, immature B-cells are tested for self-reactivity (central tolerance).
 - Strong self-reactivity (autoreactive): If the BCR binds strongly to self-antigens in the bone marrow, the B-cell may undergo:
 - Clonal deletion (apoptosis).
 - Receptor editing: A second chance to rearrange light chain genes to produce a new, non-self-reactive BCR.
 - Weak/No self-reactivity (tolerant): The B-cell survives and matures.
Mature Naïve B-cell:
- Surviving immature B-cells co-express IgM and IgD (with the same V region) on their surface and migrate from the bone marrow to secondary lymphoid organs (spleen, lymph nodes).

Role of Bone Marrow Microenvironment:

Regulates BCR construction.
Ensures each B-cell has a single antigen specificity (allelic exclusion).
Removes auto-reactive B-cells (negative selection).
Passes functional, self-tolerant B-cells to the periphery.
Can also be a site for long-lived plasma cells (antibody production) after B-cell activation.

B-Cell Subsets in Periphery:

Follicular (FO) B-cells: The major population in spleen and lymph nodes; participate in T-dependent antibody responses.
Marginal Zone (MZ) B-cells: Located in the marginal zone of the spleen; important for rapid responses to blood-borne, T-independent antigens.

III. B-Lymphocyte Activation and Differentiation

Naïve B-cells encounter antigens in secondary lymphoid organs. Activation can be T-cell dependent or T-cell independent. T-cell dependent activation leads to more robust responses, memory, and class switching.

T-Cell Dependent B-Cell Activation (e.g., in a lymph node follicle):

Antigen Recognition (Signal 1): The BCR on a naïve B-cell binds to its specific antigen. The B-cell internalizes the antigen, processes it, and presents peptide fragments on its MHC Class II molecules.
Co-stimulation and T-cell Help (Signal 2 & 3):
- The antigen-presenting B-cell interacts with an activated CD4+ T-helper cell (often a T_FH cell) that recognizes the same antigen (specifically, the peptide presented on the B-cell's MHC II).
- Key Interactions:
  - TCR (on T-cell) : MHC II-peptide (on B-cell).
  - CD40L (CD154) on T-cell : CD40 on B-cell (crucial co-stimulatory signal for B-cell activation, survival, proliferation, class switching, and somatic hypermutation).
  - CD28 (on T-cell) : CD80/86 (on B-cell, which can be upregulated after initial activation).
- Cytokines released by the T-helper cell (e.g., IL-4, IL-21) provide further signals for B-cell proliferation, differentiation, and class switching.
Germinal Center Reaction:
- Activated B-cells, with T-cell help, proliferate rapidly within B-cell follicles, forming germinal centers (GCs). Follicular Dendritic Cells (FDCs) present intact antigen to B-cells in GCs.
- Within the GC, B-cells undergo:
  - Somatic Hypermutation (SHM): Point mutations are introduced at a high rate into the V regions of Ig genes (mediated by AID). This creates variants of the original BCR, some with higher affinity for the antigen.
  - Affinity Maturation: B-cells with higher affinity BCRs are preferentially selected to survive and proliferate (by competing for antigen presented by FDCs and for T-cell help). B-cells with low affinity or self-reactive mutations undergo apoptosis.
  - Class Switch Recombination (CSR): The constant region of the Ig heavy chain is changed from Cµ (IgM) or Cδ (IgD) to Cγ (IgG), Cα (IgA), or Cε (IgE). This is also mediated by AID and directed by cytokines from T-helper cells. Class switching changes the effector function of the antibody while retaining the same antigen specificity (same VDJ region/Fab).
Differentiation:
- Selected GC B-cells differentiate into:
  - Plasma Cells: Long-lived, terminally differentiated antibody-secreting cells. They migrate to the bone marrow or mucosal tissues.
  - Memory B-cells: Long-lived cells that can mount a faster and stronger response upon re-exposure to the same antigen.

The B-Cell Journey (Summary): Naïve B-cell → (Antigen encounter + T-cell help) → Clonal expansion → (Germinal Center) Somatic hypermutation → Affinity maturation (selection of high-affinity cells, apoptosis of low-affinity/autoreactive cells) → Class switching → Differentiation into Plasma cells and Memory B-cells.

IV. Immunoglobulin Classes (Isotypes) and Functions

The class of an antibody is determined by its heavy chain constant (C) region (Fc portion) and dictates its effector functions. All classes have the same antigen-binding specificity (Fab portion) if derived from the same V(D)J rearrangement.

Immunoglobulin M (IgM):
- ~5-10% of total serum Ig.
- Exists as a monomer on the surface of naïve B-cells (as BCR).
- Secreted as a pentamer (five IgM monomers joined by a J-chain), giving it 10 antigen-binding sites, making it very effective at agglutination and complement activation.
- First antibody class produced in a primary immune response.
- Potent activator of the classical pathway of complement.
Immunoglobulin G (IgG):
- Most abundant Ig in serum (~80%).
- Monomeric.
- Four subclasses in humans: IgG1, IgG2, IgG3, IgG4 (IgG1 most abundant).
- Major antibody of secondary immune responses.
- Opsonization: IgG1 and IgG3 bind effectively to Fc receptors (FcγR) on phagocytes (e.g., macrophages, neutrophils), enhancing phagocytosis.
- Complement Activation: IgG3 is the most effective IgG subclass at activating the classical complement pathway (IgG1 and IgG2 can also activate).
- Passive Immunity to Fetus: IgG1, IgG3, and IgG4 can cross the placenta, providing passive immunity to the newborn.
- Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC): NK cells have FcγRIII (CD16) that can bind to IgG coating target cells (e.g., virus-infected cells, tumor cells), triggering NK cell degranulation and killing of the target.
Immunoglobulin A (IgA):
- ~10-15% of serum Ig (mainly monomeric).
- Dominant Ig in external secretions (e.g., tears, saliva, mucus, breast milk), where it usually exists as a dimer (two IgA monomers joined by a J-chain and associated with a secretory component that protects it from enzymatic degradation).
- Plays a central role in mucosal immunity (barrier immunity).
- The greatest amount of antibody produced daily compared to all other classes.
- Neutralization: Binds bacterial and viral antigens and prevents their attachment to mucosal epithelial cells. Its Fc region is often blocked from triggering strong inflammation at mucosal sites.
Immunoglobulin D (IgD):
- Very low levels in serum (~0.2%).
- Monomeric.
- Co-expressed with IgM on the surface of mature, naïve B-lymphocytes, acting as part of the BCR.
- May provide an activation signal to B-cells upon antigen binding.
- Might play a role in respiratory defense by activating basophils and mast cells, potentially contributing to allergy.
Immunoglobulin E (IgE):
- Least abundant Ig in serum (trace amounts), except in allergic individuals or those with parasitic infections.
- Monomeric.
- Binds with very high affinity to Fc receptors (FcεRI) on blood basophils and tissue mast cells.
- When antigen (allergen) cross-links IgE bound to these receptors, it triggers degranulation of mast cells and basophils, releasing potent pharmacologically active mediators (e.g., histamine, leukotrienes, prostaglandins) and cytokines/chemokines.
- Primary role in defense against helminthic parasites and in allergic reactions (Type I hypersensitivity).

General Antibody Effector Functions:

Neutralization: Antibodies bind to pathogens (e.g., viruses, bacteria) or toxins, preventing them from attaching to or entering host cells, or neutralizing their harmful effects.
Opsonization: Antibodies (especially IgG) coat pathogens, marking them for enhanced phagocytosis by cells with Fc receptors.
Agglutination: Antibodies, particularly multivalent ones like IgM (pentameric) and IgA (dimeric), can cross-link particulate antigens (like bacteria), causing them to clump together, making them easier for phagocytes to clear.
Complement Activation: IgM and certain IgG subclasses can activate the classical complement pathway, leading to pathogen lysis, opsonization (C3b), and inflammation.
Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC): Antibodies (mainly IgG) bound to target cells can be recognized by Fc receptors on NK cells (and other cells like eosinophils), leading to the killing of the target cell.
Innate Immune Cell Recruitment/Activation: Fc regions of antibodies can bind to Fc receptors on various innate immune cells, triggering their activation and effector functions (e.g., mast cell degranulation by IgE).